🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Sulfur burps protocol — need advice

Sulfur burps protocol — need advice

pete_RVA Thu, Jan 9, 2025 at 10:04 AM 15 replies 1,876 viewsPage 1 of 3
This thread is more than 17 months old. Information may be outdated. Consider searching for more recent discussions.
pete_RVA
Member
178
890
Dec 2024
Richmond, VA
Jan 9, 2025 at 10:04 AM#1

This is the version of the explanation I wish somebody had given me, written down before I forget what confused me. It is about nausea, and it is deliberately narrow — everything I am not confident about is marked as such.

What is actually established

The practical protocol is dull and it works: smaller meals, stop eating at the first sign of fullness rather than at the end of the plate, drop the fat fraction of meals in the two days after dosing, and do not lie down straight after eating. Most of what people call unmanageable nausea is a meal-size and meal-composition problem interacting with a stomach that is emptying slowly.

The condition it depends on

A caveat: adaptation applies to gastric emptying and not to everything. If your problem is the aversion rather than the fullness, waiting does less, because the aversion is central and it is the mechanism working as intended.

The practical version

Trial-level incidence runs roughly 20 to 25% for nausea at the higher dose tiers and 12 to 17% for diarrhoea, with most events mild to moderate and concentrated in the weeks after each escalation.

What I am not sure about

The bit I cannot resolve on my own is what distinguishes the nausea you can titrate through from the nausea that means stop. If the honest answer is that nobody knows, that is a useful answer and I would rather have it.

— pete_RVA · corrections welcome and will be edited into this post with credit
10 13mike_mod, SarahChen_PharmD, sarah.morrison and 7 others
Reply Quote Save Share Report
BariatricNurseD
Senior Member
1,678
7,234
Feb 2024
Dallas, TX
Online
Jan 9, 2025 at 11:00 AM#2
pete_RVA said:
The practical protocol is dull and it works: smaller meals, stop eating at the first sign of fullness rather than at the end of the plate, drop the…

No disagreement with pete_RVA. One condition attached. Holding genuinely reduces total burden rather than redistributing it, because the gastric-emptying component adapts. Receptor-level tachyphylaxis to the delayed-emptying effect develops over weeks while the central appetite effect persists, so the same dose is materially more comfortable at week six than at week two. A slower ladder therefore reaches the same dose with less cumulative nausea, not the same nausea spread thinner.

Correct me if the detail matters more than I have assumed.

Last edited: Jan 9, 2025 at 4:00 PM
11 14roxy_nash, tony_orlando, Dr.NephBHM_UK and 8 others
Reply Quote Save Share Report
PharmD_Rodriguez
Senior Member
3,456
14,567
Jan 2024
Miami, FL
Jan 9, 2025 at 11:56 AM#3
pete_RVA said:
The practical protocol is dull and it works: smaller meals, stop eating at the first sign of fullness rather than at the end of the plate, drop the…

I dislike how confidently this board tells people to push through. Incidence figures around 20 to 25% at the higher doses are class-typical, but the trials also had a discontinuation column, and "manageable with protocols" is not the same as manageable for everyone.

That is the short version; the long version is somebody else's post.

Last edited: Jan 9, 2025 at 4:56 PM
12 15robert_kc, dan_philly, MeganSA_TX and 9 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
DebRD_ATL
Senior Member
1,678
7,890
Feb 2024
Atlanta, GA
Jan 9, 2025 at 12:53 PM#4

Taking the question as asked, rather than the general version of it. The line between titrate-through and stop is not severity, it is trajectory and what else is present. Nausea that peaks and improves within a week is the expected pattern. Nausea that is escalating, or that comes with severe upper-abdominal pain radiating to the back, or that prevents fluids for more than a day, is a different conversation and belongs with a clinician the same day.

13 16PedsEndoPhilly, SleepDoc_PDX, RegAffairsDC and 10 others
Reply Quote Save Share Report
AussieAnna
Member
678
2,890
Jun 2024
Sydney, AU
Jan 9, 2025 at 6:15 PM#5
BariatricNurseD said:
Holding genuinely reduces total burden rather than redistributing it, because the gastric-emptying component adapts.

This matches mine closely enough to be worth saying so out loud.

Last edited: Jan 9, 2025 at 7:15 PM
14 17pete_manc_UK, anna.melb_AU, mark_tokyo and 11 others
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register